Page last updated: 2024-09-05

1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride and Body Weight, Fetal

1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride has been researched along with Body Weight, Fetal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, TH; Chung, MK; Jang, BS; Kang, SS; Kim, CY; Kim, JC; Kim, SH; Shin, DH1

Other Studies

1 other study(ies) available for 1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride and Body Weight, Fetal

ArticleYear
Developmental toxicity evaluation of the new fluoroquinolone antibacterial DW-116 in rats.
    Teratogenesis, carcinogenesis, and mutagenesis, 2003, Volume: Suppl 1

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Infective Agents; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Female; Fetal Weight; Fetus; Fluoroquinolones; Gestational Age; Maternal-Fetal Exchange; Molecular Structure; Organ Size; Piperazines; Placenta; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley

2003